Amryt Pharma publishes scheme circular, announces shareholder meetings

Amryt Pharma announced today that it has published a scheme circular to its shareholders regarding the Amryt shareholder meetings to be held to consider and vote on the proposed acquisition of Amryt by Chiesi Farmaceutici S.p.A., an Italian societa per azioni. As set forth in the Scheme Circular, the Amryt shareholder meetings for the Transaction will be held in London, UK on March 22, 2023. The Amryt Board of Directors unanimously recommends that Amryt shareholders vote "FOR" all of the Transaction-related proposals at the shareholder meetings. Holders of record of Amryt ordinary shares as of 6:00 p.m. on March 20, 2023 will be entitled to vote at the shareholder meetings. Holders of American Depositary Shares of Amryt as of February 10, 2023 at 5:00 p.m. will be entitled to deliver voting instructions to vote at the shareholder meetings, but will not be entitled to attend the meetings.